Letter to the Editor
Therapeutic Thrombocytapheresis for Symptomatic Thrombocytosis in Hemato-Oncology Patients
Satya Prakash,
Satya Prakash
Department of Transfusion Medicine, Post-graduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author Rekha Hans,
Rekha Hans
Department of Transfusion Medicine, Post-graduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author Ratti R. Sharma,
Corresponding Author
Ratti R. Sharma
Department of Transfusion Medicine, Post-graduate Institute of Medical Education and Research, Chandigarh, India
Email:
[email protected]Search for more papers by this author Pankaj Malhotra,
Pankaj Malhotra
Department of Internal Medicine, Post-graduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author Neelam Marwaha,
Neelam Marwaha
Department of Transfusion Medicine, Post-graduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author
Satya Prakash,
Satya Prakash
Department of Transfusion Medicine, Post-graduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author Rekha Hans,
Rekha Hans
Department of Transfusion Medicine, Post-graduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author Ratti R. Sharma,
Corresponding Author
Ratti R. Sharma
Department of Transfusion Medicine, Post-graduate Institute of Medical Education and Research, Chandigarh, India
Email:
[email protected]Search for more papers by this author Pankaj Malhotra,
Pankaj Malhotra
Department of Internal Medicine, Post-graduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author Neelam Marwaha,
Neelam Marwaha
Department of Transfusion Medicine, Post-graduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author
First published: 04 December 2017
No abstract is available for this article.
REFERENCES
- 1Schwartz J, Padmanabhan A, Aqui N et al. Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the writing committee of the American Society for Apheresis: the seventh special issue. J Clin Apher 2016; 31: 315–316.
- 2Carobbio A, Thiele J, Passamonti F et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood 2011; 117: 5857–9.
- 3Finazzi G, Carobbio A, Thiele J et al. Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibroticmyelofibrosis diagnosed according to the 2008 WHO criteria. Leukemia 2012; 26: 716–9.
- 4Thakral B, Saluja K, Malhotra P, Sharma RR, Marwaha N, Varma S. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia. Ther Apher Dial 2004; 8: 497–9.
- 5Hans R, Prakash S, Sharma RR, Marwaha N. Therapeutic thrombocytapheresis for symptomatic thrombocytosis in hemato-oncology patients-A case series [abstract]. Vox Sang 2015; 109: 1–379.
